Curr Diab Rep (2017) 17: 131 https://doi.org/10.1007/s11892-017-0965-1 THERAPIES AND NEW TECHNOLOGIES IN THE TREATMENT OF TYPE 1 DIABETES (M PIETROPAOLO, SECTION EDITOR) Reporting Severe Hypoglycemia in Type 1 Diabetes: Facts and Pitfalls 1,2 1,2 Ulrik Pedersen-Bjergaard & Birger Thorsteinsson Published online: 28 October 2017 Springer Science+Business Media, LLC 2017 . . Abstract Keywords Type 1 diabetes Severe hypoglycemia . . Purpose of Review To describe potential factors influencing Incidence Prevalence Reporting bias reporting of severe hypoglycemia in adult patients with type 1 diabetes and to analyze their effect on reported rates of severe hypoglycemia. Introduction Recent Findings Reported rates of severe hypoglycemia defined as need for third party assistance vary between 0.3– Severe hypoglycemia remains the main serious side effect of 3.0 events per patient-year in unselected cohorts, corresponding insulin replacement therapy in type 1 diabetes [1, 2]. to a yearly prevalence range of 10–53%. When defined as need Information about the epidemiology of severe hypoglycemia for parenteral therapy with glucose or glucagon or need for in the diabetic population is an important measure of quality of admission to an emergency unit or hospitalization, incidence treatment. Highly conflicting results exist in the literature on and prevalence rates of severe
Current Diabetes Reports – Springer Journals
Published: Oct 28, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera